Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by CancerSlayeron Jun 13, 2022 11:16pm
201 Views
Post# 34754053

RE:Time for some good news.

RE:Time for some good news.
Infinity wrote: I am hoping that the management would do something to bring up the stock price and the market cap.  They would need to release any news for that matter that show cases that the company is cruising in the right direction and the strategic plans that are in place are being worked dillgently.  Literally any development that would improve the image of the company as a serious contender for BTD and or AA.   I think the company cannot release any data on clinical studies at this point.  They can certainly release
1.  News on Strategic plans from the CEO and CFO, since RDW cannot comment openly.
2.  Progress report after shifting to Li Ka Shing Knowledge institute/ St Michaels Hospital.
3.  Immediate and future plans from Dr. Madzervic would be a bonus.  Now that she has been with the company for little under one year.  Her thoughts on the company's path to market the PDT as a viable alternative or supplemental program to BCG
4,  New contracts signed for device sales or Cool Laser Tech update. 
5. New clients enrolled and the growing number of Chiropractors and Physiotherapist who have started offering Cool laser as an integral part of any physical rehab programs.


This is required immediately to peg the down ward slide of the stock prices, improve investor sentimets!!



They have all hands on the NMIBC deck...as they should.  However, in the near term, the best remedy for any skeptical investor sentiment is not only the obvious = more durable response data, but also a clear presentation of that data.  In the context of having limited/BTD-worthy data, it would be helpful to see optimized & non-optimized data presented separately.  It would also be helpful to see this data reported in absolute numbers...unfortunately, a percentage of an unknown number is still an unknown number...JMO.  A "significant" Li Ka Shing update would be icing on the cake, but single-layer icing tends to melt when spread too early.

<< Previous
Bullboard Posts
Next >>